By Jonah Comstock February 15, 2017 GluSense, an Israeli medical device company, announced an undisclosed investment from the JDRF T1D Fund, a recently launched VC philanthropy fund dedicated to funding early…

Medial EarlySign’s software analyzes digital records to identify health risks and existing conditions that may not even be causing symptoms. By Abigail Klein Leichman FEBRUARY 9, 2017, 7:00 AM Your…

Revolutionary Israeli device can eliminate need for follow-up breast cancer surgery MarginProbe, which checks tumor’s edges while lumpectomy patient is still on operating table, is already in use in over…

From Jaffa oranges to Waze to medicinal cannabis? Will medical marijuana be the next big Israeli export? Israel’s burgeoning medicinal cannabis scene enjoyed a small victory on Sunday when a…

US-based CA Technologies announced yesterday that they have signed an agreement that would see them acquire #Israeli performance #testing #startup BlazeMeter. While the terms of the deal have not been released,…

Harnessing real-time data and machine learning, this startup wants to change how business intelligence works for you   #Israeli #incident #detection and #analytics #startup #Anodot announced on Thursday the close…

Israel-based Intensix’s software tries to anticipate changes in a patient’s condition before they happen Israel's private hospital network Assuta seeks to press its advantage by investing in the local tech…

Stanford University researchers say that they’ve trained a deep learning algorithm to identify skin cancer as well as dermatologists. A dermatologist uses a handheld microscope called a dermatoscope to examine…